Women's cannabis use before, during, and after pregnancy in New Hampshire.
Women's cannabis use before, during, and after pregnancy in New Hampshire.
复制标题
DOI：
10.1016/j.pmedr.2020.101262
复制
发表时间：
2020-12
影响因子：
2.8
通讯作者：
Benjamin-Neelon SE
中科院分区：
文献类型：
--
作者：
Skelton KR;Hecht AA;Benjamin-Neelon SE
自我报告的大麻使用流行率在怀孕前最高。产前大麻使用者最常报告使用大麻作为止吐剂。在怀孕前后，使用大麻的首要原因是缓解压力或焦虑。未来的研究应探讨在这些时期的使用模式和动机。大麻在美国的使用一直在稳步增加。与尚未合法化的州相比，在娱乐性大麻法律的州，对大麻使用者的了解要多得多。此外，关于在产妇和儿童健康关键时期使用大麻的原因，所知甚少。为了解决这一差距，我们研究了新罕布什尔州妇女在孕前、产前和产后期间使用大麻的情况，并探讨了使用大麻的原因。我们在2020年春季分析了2016-2017年妊娠风险评估监测系统（PRAMS）的数据。对于分娩活产婴儿的妇女，PRAMS收集怀孕前、怀孕期间和怀孕后的行为和经验数据。使用来自新罕布什尔州的数据，我们估计了在孕前、产前和产后期间自我报告的大麻使用的加权患病率，以及在每个时期使用大麻的原因。在纳入分析的1147名妇女中，16.8%（未加权n = 186）报告了孕前大麻使用，5.5%（未加权n = 68）报告了产前大麻使用，6.6%（未加权n = 73）报告了产后大麻使用。大约五分之一（20.3%）报告使用大麻的女性在这三个时期都报告使用过大麻。在怀孕前和产后使用大麻的最主要原因是缓解压力或焦虑（分别为64.88%和73.06%），在产前期间使用大麻是为了止吐（84.1%）。我们的研究结果支持妇女的医疗保健提供者应该筛查大麻使用的患者，解决根本原因（例如，心理健康问题、恶心/呕吐），以用作筛选过程的一部分。
Self-reported prevalence of cannabis use was highest before pregnancy. Prenatal cannabis users most frequently reported using cannabis as an antiemetic. Before and after pregnancy, the top reason for cannabis use was to relieve stress or anxiety. Future research should examine use patterns and motives during these periods. Cannabis use in the United States has been steadily increasing. Much more is known about cannabis users in states where recreational cannabis is legal, compared to states yet to legalize. Further, there is little information known about reasons for cannabis use during critical maternal and child health periods. To address this gap, we examined cannabis use among New Hampshire women during the preconception, prenatal, and postpartum periods, and explored reasons for use. We analyzed data from the 2016–2017 Pregnancy Risk Assessment Monitoring System (PRAMS) in the Spring of 2020. For women delivering a live-born infant, PRAMS collects behavior and experience data before, during, and after pregnancy. Using data from New Hampshire, we estimated the weighted prevalence of self-reported cannabis use during the preconception, prenatal, and postpartum periods, and reasons for use during each period. Of the 1147 women included in the analysis, 16.8% (unweighted n = 186) reported preconception cannabis use, 5.5% (unweighted n = 68) reported prenatal cannabis use, and 6.6% (unweighted n = 73) reported postpartum cannabis use. About one-fifth (20.3%) of women who reported cannabis use reported use during all three periods. The top reason for cannabis use during preconception and postpartum was for stress or anxiety relief (64.88% and 73.06, respectively), and during the prenatal period was for its’ antiemetic properties (84.1%). Our findings support that women’s healthcare providers should screen patients for cannabis use, addressing underlying reasons (e.g., mental health issues, nausea/vomiting) for use as part of the screening process.
登录
查看更多内容
DOI：
10.1080/14767058.2020.1765157
发表时间：
2020-05-14
影响因子：
1.8
作者：
Lee, Emily;Pluym, Ilina D.;Rao, Rashmi
通讯作者：
Rao, Rashmi
影响因子：
3.8
作者：
Latuskie, Kiri A.;Andrews, Naomi C. Z.;Pepler, Debra J.
通讯作者：
Pepler, Debra J.
影响因子：
8
作者：
Bertrand, Kerri A.;Hanan, Nathan J.;Chambers, Christina D.
通讯作者：
Chambers, Christina D.
影响因子：
4.2
作者：
Chang, Judy C.;Tarr, Jill A.;Arnold, Robert M.
通讯作者：
Arnold, Robert M.
影响因子：
5.5
作者：
Short, Vanessa L.;Hand, Dennis J.;Abatemarco, Diane J.
通讯作者：
Abatemarco, Diane J.